ACIP Recommendations: Measles, Mumps and Rubella (MMR) Vaccine

Published in Morbidity and Mortality Weekly Report (MMWR)

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

CURRENT MMR vaccine recommendations

MMWR, November 18, 2022, Vol 71(46);1465–70
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Print version

MMWR, January 12, 2018, Vol 67(1);33–38
Recommendations of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak
Print version

MMWR, June 14, 2013, Vol 62(RR-04);1-34
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 Summary: Recommendations of the ACIP
Print version

See also:
MMRV ACIP Recommendations (includes varicella)

ARCHIVED historical MMR immunization publications

For your convenience, these archived publications can be used for historical and research purposes.

MMWR, June 9, 2006, Vol 55(22);629-630
Notice to Readers: Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) for the Control and Elimination of Mumps
Print version

MMWR, December 14, 2001, Vol 50(49);1117
Notice to Readers: Revised ACIP Recommendation for Avoiding Pregnancy After Receiving a Rubella-Containing Vaccine
Print version

MMWR, May 22, 1998, Vol 47(RR-8);1-57
MMR—Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps
Print version